Dr Paul Stoffels, Executive Vice President and Chief Scientific Officer for Johnson & Johnson, answers questions pertinent to the 2016 International Aids Conference.
Who is Dr Paul Stoffels?
Why is Johnson & Johnson so invested in HIV research and what are you trying to achieve?
What is needed to conclusively end the Aids epidemic?
How does Johnson & Johnson support the effort to end the Aids epidemic?
Why is a vaccine so important and what is so special about yours?
What would be the next step for the vaccine?
What was the strategy behind your recent launch of operations in Africa?
Do you think it is realistic to think that AIDS can be completely eradicated by 2030?